Varaico: Literature-Extracted Genetic Variants

Gene:NR0B1
Variant:p.R267P
Back to variants list

NR0B1

NM_000475.5:p.R267P

Associated Papers

A scalable approach to resolving variants of uncertain significance.

Tejura M et al.

Biorxiv : the Preprint Server for Biology, 2026

41727046 (PubMed )
Supplement: media-7.xlsx › VarChAMP_data_supp_mat_PP

Are transient protein-protein interactions more dispensable?

Ghadie MA et al.

Plos Computational Biology, 2022

35404956 (PubMed )
Supplement: pcbi.1010013.s002.xlsx › _B__Y2H-SI_disMut_edgotypes

Mutation Edgotype Drives Fitness Effect in Human.

Ghadie M et al.

Frontiers in Bioinformatics, 2021

36303776 (PubMed )
Supplement: Table2.XLSX › _B__Y2H-SI_pathMt_edgotype

Estimating dispensable content in the human interactome.

Ghadie M et al.

Nature Communications, 2019

31324802 (PubMed )
Supplement: 41467_2019_11180_MOESM6_ESM.xlsx › _B__Y2H-SI_disease_mut

Late-onset X-linked adrenal hypoplasia (DAX-1, NR0B1): two new adult-onset cases from a single center.

Kyriakakis N et al.

Pituitary, 2017

A novel DAX1/NR0B1 mutation in a patient with adrenal hypoplasia congenita and hypogonadotropic hypogonadism.

Battistin C et al.

Arquivos Brasileiros De Endocrinologia E Metabologia, 2012

Role of DAX-1 (NR0B1) and steroidogenic factor-1 (NR5A1) in human adrenal function.

El-Khairi R et al.

Endocrine Development, 2011

Seven novel DAX1 mutations with loss of function identified in Chinese patients with congenital adrenal hypoplasia.

Li N et al.

The Journal of Clinical Endocrinology and Metabolism, 2010

CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease.

Ferraz-de-Souza B et al.

The Journal of Clinical Endocrinology and Metabolism, 2009

Disorders of adrenal development.

Ferraz-de-Souza B et al.

Endocrine Development, 2008

A novel missense mutation in DAX-1 with an unusual presentation of X-linked adrenal hypoplasia congenita.

Ahmad I et al.

Hormone Research, 2007

Genetic disorders involving adrenal development.

Lin L et al.

Endocrine Development, 2007

Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience.

Lin L et al.

The Journal of Clinical Endocrinology and Metabolism, 2006

A familial missense mutation in the hinge region of DAX1 associated with late-onset AHC in a prepubertal female.

Bernard P et al.

Molecular Genetics and Metabolism, 2006

Structure-function analysis reveals the molecular determinants of the impaired biological function of DAX-1 mutants in AHC patients.

Lehmann SG et al.

Human Molecular Genetics, 2003

Genetic approaches to unraveling reproductive disorders: examples of bedside to bench research in the genomic era.

Seminara SB et al.

Endocrine Reviews, 2002

Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1.

Holter E et al.

Molecular Endocrinology (baltimore, Md.), 2002

Mutations in NR0B1 (DAX1) and NR5A1 (SF1) responsible for adrenal hypoplasia congenita.

Phelan JK et al.

Human Mutation, 2001

Missense mutations cluster within the carboxyl-terminal region of DAX-1 and impair transcriptional repression.

Achermann JC et al.

The Journal of Clinical Endocrinology and Metabolism, 2001

Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA.

Lalli E et al.

Molecular and Cellular Biology, 2000

Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita.

Altincicek B et al.

The Journal of Biological Chemistry, 2000

A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism.

Tabarin A et al.

The Journal of Clinical Investigation, 2000

DAX-1, an 'antitestis' gene.

Goodfellow PN et al.

Cellular and Molecular Life Sciences : Cmls, 1999

A microdeletion within DAX-1 in X-linked adrenal hypoplasia congenita and hypogonadotrophic hypogonadism.

Wang J et al.

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research, 1999

Novel DAX1 mutations in X-linked adrenal hypoplasia congenita and hypogonadotrophic hypogonadism.

Bassett JH et al.

Clinical Endocrinology, 1999

Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations.

Seminara SB et al.

Endocrine Reviews, 1998

Congenital adrenal hypoplasia: clinical spectrum, experience with hormonal diagnosis, and report on new point mutations of the DAX-1 gene.

Peter M et al.

The Journal of Clinical Endocrinology and Metabolism, 1998

Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1.

Crawford PA et al.

Molecular and Cellular Biology, 1998

DAX1 mutations map to putative structural domains in a deduced three-dimensional model.

Zhang YH et al.

American Journal of Human Genetics, 1998

Three novel mutations and a de novo deletion mutation of the DAX-1 gene in patients with X-linked adrenal hypoplasia congenita.

Nakae J et al.

The Journal of Clinical Endocrinology and Metabolism, 1997

DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita.

Ito M et al.

Molecular and Cellular Biology, 1997

X-linked adrenal hypoplasia in a large Greenlandic family. Detection of a missense mutation (N4401) in the DAX-1 gene; implication for genetic counselling and carrier diagnosis.

Schwartz M et al.

Human Genetics, 1997

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."